KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
3.210
-0.040 (-1.23%)
May 13, 2025, 4:00 PM - Market closed
KORU Medical Systems Revenue
KORU Medical Systems had revenue of $9.64M in the quarter ending March 31, 2025, with 17.53% growth. This brings the company's revenue in the last twelve months to $35.08M, up 19.65% year-over-year. In the year 2024, KORU Medical Systems had annual revenue of $33.65M with 17.98% growth.
Revenue (ttm)
$35.08M
Revenue Growth
+19.65%
P/S Ratio
4.20
Revenue / Employee
$438,547
Employees
80
Market Cap
147.52M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.65M | 5.13M | 17.98% |
Dec 31, 2023 | 28.52M | 621.63K | 2.23% |
Dec 31, 2022 | 27.90M | 4.41M | 18.76% |
Dec 31, 2021 | 23.49M | -686.27K | -2.84% |
Dec 31, 2020 | 24.18M | 1.01M | 4.38% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
KRMD News
- 2 days ago - KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance - Business Wire
- 2 months ago - KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance - Business Wire
- 2 months ago - KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 - Business Wire
- 3 months ago - KORU Medical Systems Has A Long Runway - Seeking Alpha
- 3 months ago - KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System - Business Wire
- 3 months ago - KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology - Business Wire